Volume 14, Number 12—December 2008
CME ACTIVITY
Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel
Ronit Zaidenstein, Chantal Sadik, Larisa Lerner, Lea Valinsky, June Kopelowitz, Ruth Yishai, Vered Agmon, Michele Parsons, Cheryl Bopp, and Miriam Weinberger
Table 2
Variables associated with death in laboratory-confirmed Vibrio vulnificus infection, by univariable analysis, Israel, 1998–2005*
| Clinical characteristics | Alive,† n = 84 | Dead,† n = 10 | p value |
|---|---|---|---|
| Mean age ± SD, y | 62.3 ± 18.2 | 69.2 ± 15.8 | NS |
| Female, no. (%) | 60 (49.2) | 8 (80) | NS |
| Septic shock, no. (%) | 41 (4.9)† | 6 (60) | <0.001 |
| Bacteremia, no. (%) | 24 (28.6) | 7 (70) | 0.013 |
| Ischemic heart disease, no. (%) | 4 (4.8) | 4 (40) | 0.004 |
| Altered immune status,‡ no. (%) | 6 (7.1) | 3 (30) | 0.052 |
*NS, not significant.
†n = 81.
‡Due to malignancy or immunosuppressive state.
